Physician

Azhar Zahir

According to 2025 Medicare claims, Azhar Zahir (NPI: 1750465258) practices internal medicine in the Las Cruces, NM market, with the plurality of this provider's patient population coming from Dona Ana, NM. This provider's primary affiliated billing organization is SOUTHWEST HEALTHCARE ASSOCIATES LLC (NPI: 1265434807; TIN: 850481272) and primary practice location at 88011-8266.

Zahir's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 955 traditional Medicare patients, billed 5,482 HCPCS/CPT codes, and received $359,936 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 16,515 prescription claims across 1,038 beneficiaries totaling $1,775,996 in drug costs, led by Ozempic (Semaglutide). DME data shows 216 claims. Open Payments data shows 10 records totaling $195. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,169,573 to $1,775,996. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $130,248 to $31,261.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,543	9,649	$474,552
2016	1,263	8,006	$406,640
2017	1,323	7,869	$373,454
2018	1,447	8,555	$441,250
2019	1,417	8,019	$443,883
2020	1,508	8,008	$465,554
2021	1,627	7,282	$438,614
2022	1,407	6,785	$407,541
2023	1,102	5,816	$364,375
2024	955	5,482	$359,936

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	862	18,837	$1,169,573
2016	885	18,757	$1,182,266
2017	891	16,757	$1,152,562
2018	918	16,451	$1,218,144
2019	920	16,084	$1,361,210
2020	951	16,759	$1,451,347
2021	977	16,254	$1,547,276
2022	1,007	16,309	$1,648,592
2023	1,014	16,074	$1,810,410
2024	1,038	16,515	$1,775,996

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	417	1,801	$111,116
2016	351	1,552	$118,875
2017	195	1,042	$54,530
2018	153	842	$29,100
2019	150	681	$24,942
2020	130	590	$27,514
2021	97	510	$22,234
2022	87	485	$27,808
2023	69	428	$61,282
2024	21	216	$23,478

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	684	1,903	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	216	340	$63
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	162	1,430	$60
94010	Test to measure expiratory airflow and volume	254	262	$18
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	293	315	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	225	9,564	$281,651
Eliquis	Apixaban	214	9,539	$181,858
Jardiance	Empagliflozin	148	8,176	$155,160
Prolia	Denosumab	56	9,798	$98,165
Farxiga	Dapagliflozin Propanediol	85	4,900	$93,300

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	36	$15,557
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	83	$6,293
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	21	54	$895
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$422
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	18	$295

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$195	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Azhar Zahir?

Tedicare shows public-source Medicare data for Azhar Zahir (NPI 1750465258), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Azhar Zahir have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Azhar Zahir?

Azhar Zahir is linked to SOUTHWEST HEALTHCARE ASSOCIATES LLC (billing NPI 1265434807) in the available physician profile data.

Does Azhar Zahir have Open Payments data?

Azhar Zahir has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.